PROBIOTIC (INFANT) FOOD
First Claim
1. A composition, preferably an infants food, comprising a lipid source, a carbohydrate source and a low-allergenic casein hydrolysate with peptides of maximally 3000 daltons, characterized in that the composition further contains the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to foods, such as infants and children'"'"'s food and dietary supplements for infants and children. The invention provides a composition comprising a lipid source, a carbohydrate source and a protein source, characterized in that the composition further contains the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544. Such a composition contributes to the general resistance, in particular with respect to undesired passage of pathogens and the incidence of respiratory diseases in children.
52 Citations
22 Claims
- 1. A composition, preferably an infants food, comprising a lipid source, a carbohydrate source and a low-allergenic casein hydrolysate with peptides of maximally 3000 daltons, characterized in that the composition further contains the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544.
- 14. The use of a composition comprising a lipid source a carbohydrate source and a low-allergenic casein hydrolysate with peptides of maximally 3000 daltons, characterized in that the composition further contains the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544 wherein the composition contains 103 to 109, preferably minimally 106-107, colony-forming units per bacterial strain per gram of dry product for treating or preventing symptoms associated with allergy for ruminant milk proteins.
-
17. The use of the B. lactis strain deposited under ATCC number 27536 in combination with the L. casei strain deposited under ATCC number 55544 for the preparation of a preventive or therapeutic composition for prevention or treatment of infectious diseases of the gastrointestinal tract, the airways and sinus cavity, the ears or ear cavities, the eyes, the urinary system, the internal and external surfaces of genitals and the skin of people in general, and respiratory diseases in infants and children in particular.
- 19. A mixture of the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544.
Specification